Hennion & Walsh Asset Management’s Day One Biopharmaceuticals DAWN Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $629K | Sell |
96,821
-41,147
| -30% | -$267K | 0.03% | 604 |
|
|
2025
Q1 | $1.09M | Buy |
137,968
+16,801
| +14% | +$133K | 0.05% | 454 |
|
|
2024
Q4 | $1.54M | Buy |
121,167
+57,601
| +91% | +$730K | 0.07% | 353 |
|
|
2024
Q3 | $885K | Sell |
63,566
-793
| -1% | -$11K | 0.04% | 474 |
|
|
2024
Q2 | $887K | Buy |
64,359
+5,070
| +9% | +$69.9K | 0.05% | 453 |
|
|
2024
Q1 | $979K | Buy |
59,289
+1,445
| +2% | +$23.9K | 0.05% | 423 |
|
|
2023
Q4 | $845K | Buy |
57,844
+4,041
| +8% | +$59K | 0.05% | 445 |
|
|
2023
Q3 | $660K | Buy |
53,803
+25,414
| +90% | +$312K | 0.04% | 451 |
|
|
2023
Q2 | $339K | Buy |
+28,389
| New | +$339K | 0.02% | 616 |
|